Pacific Heights Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Pacific Heights Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,000	Closed	-$269K	–	73
2023 Q4	$269K	Hold	21,000	–	–	0.02%	74
2023 Q3	$777K	Hold	21,000	–	–	0.07%	73
2023 Q2	$845K	Hold	21,000	–	–	0.08%	73
2023 Q1	$1.52M	Hold	21,000	–	–	0.14%	75
2022 Q4	$1.72M	Hold	21,000	–	–	0.17%	75
2022 Q3	$1.98M	Hold	21,000	–	–	0.21%	78
2022 Q2	$4.09M	Hold	21,000	–	–	0.42%	71
2022 Q1	$4.88M	Hold	21,000	–	–	0.42%	70
2021 Q4	$8.27M	Hold	21,000	–	–	0.7%	50
2021 Q3	$9.4M	Hold	21,000	–	–	0.89%	44
2021 Q2	$8.16M	Buy	21,000 +4,000	+24%	+$1.43M	0.75%	47
2021 Q1	$6.1M	Buy	17,000 +6,000	+55%	+$2.65M	0.56%	57
2020 Q4	$5.4M	Hold	11,000	–	–	0.53%	58
2020 Q3	$3.56M	Hold	11,000	–	–	0.46%	59
2020 Q2	$4.01M	Buy	11,000 +880	+9%	+$222K	0.6%	52
2020 Q1	$2.84M	Buy	10,120 +3,120	+45%	+$990K	0.48%	61
2019 Q4	$2.88M	Hold	7,000	–	–	0.36%	69
2019 Q3	$2.47M	Hold	7,000	–	–	0.33%	70
2019 Q2	$3.52M	Hold	7,000	–	–	0.46%	66
2019 Q1	$6.96M	Buy	7,000 +2,000	+40%	+$1.86M	0.91%	38
2018 Q4	$4.34M	Hold	5,000	–	–	0.59%	57
2018 Q3	$5.17M	Hold	5,000	–	–	0.57%	61
2018 Q2	$4.59M	Hold	5,000	–	–	0.47%	64
2018 Q1	$4.88M	Buy	5,000 +4,000	+400%	+$3.65M	0.52%	62
2017 Q4	$453K	Buy	+1,000	New	+$369K	0.04%	74

Other funds holding ATRA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pacific Heights Asset Management's ATRA Position: Q1 2024 in Review

Pacific Heights Asset Management sold out of Atara Biotherapeutics (ATRA) in Q1 2024, closing a stake of 21,000 shares — an estimated $269K sold.

Pacific Heights Asset Management first reported a position in ATRA in Q4 2017 and held it in 25 quarters. The position peaked at $9.4M in Q3 2021. 82 funds tracked by Wall St. Rank hold ATRA as of Q1 2024.

Pacific Heights Asset Management reported no remaining Atara Biotherapeutics position as of Q1 2024 after selling out during the quarter.
Pacific Heights Asset Management sold 21,000 Atara Biotherapeutics shares in Q1 2024, an estimated $269K.
Pacific Heights Asset Management first reported a position in Atara Biotherapeutics in Q4 2017 and held it in 25 quarters.
Pacific Heights Asset Management's Atara Biotherapeutics position peaked at $9.4M in Q3 2021.
82 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2024.

Based on Pacific Heights Asset Management's 13F filing for Q1 2024, filed 26 Apr 2024.